Local production of growth factors may play a major role in vascular repair after injury. We examined the regulation of insulin-like growth factor-I (IGF-I) and its specific membrane receptor in balloon-denuded rat aorta. Aortic IGF-I mRNA and radioimmunoassayable IGF-I content increased severalfold after balloon denudation with a peak at 7 d after injury. This coincided with a reciprocal 25% decrease in IGF-I receptor mRNA content and a 40% decrease in total '25I-IGF-I binding.
Introduction
Vascular smooth muscle cell (SMC)' proliferation is the cardinal feature of arterial wall response to injury ( 1 ). Although the signaling events leading to SMC proliferation have not been clearly defined, platelet-derived growth factor (PDGF) released by adhering platelets has been implicated as a potential initial stimulus (2) . Recently, it has been shown that PDGF is also produced by vascular SMC within the vessel wall after balloon denudation (3) , suggesting that autocrine or paracrine production of growth factors may be important in vascular repair. Insulin-like growth factor-I (IGF-I), a ubiquitously expressed polypeptide (M, 7, 649 ) with high degree of structural homology with proinsulin, also stimulates a number ofgrowthassociated processes in various tissues (4) . Support for the role of IGF-I in the process of SMC proliferation comes from in vitro studies demonstrating that in addition to PDGF, aortic SMC require IGF-I to progress fully through the cell cycle (5) . This is compatible with a model of cell cycle progression in mesenchymal cells in which growth factors act at discrete stages in the process of cell division (6) . PDGF regulates the initial event in the mitogenic response by rendering the Go arrested cells competent to replicate their DNA and divide. However, the cells will not complete the process in the absence of additional factors, such as epidermal growth factor or IGF-I, which regulate progression through GI to the S phase ofthe cell cycle.
This mechanism may also operate in vivo. We found induction of aortic IGF-I mRNA content after balloon denudation (7) , indicating that local production of this growth factor may be a critical permissive factor for vascular SMC proliferation.
The purpose of the present study was to examine whether IGF-I accumulates in the vessel wall after balloon denudation and exerts its growth-promoting effects through interaction with specific IGF-I receptors. Furthermore, we examined the cellular source of IGF-I in the vessel wall, and the cells which may be the target of its action. We report that after balloon denudation of rat aorta, increased SMC IGF-I gene expression is associated with IGF-I receptor downregulation, and that these events take place with a reciprocal time course, supporting a role for local IGF-I gene expression and action in vascular tissue after injury.
Methods
Animals. Adult male Sprague-Dawley rats (400-500 g) were anesthetized with intraperitoneal pentobarbital. Balloon denudation of the aorta was performed with an inflated F2 Fogarty catheter, introduced through the right femoral artery and pulled with inflated balloon from the aortic arch into the abdominal aorta three times. The femoral artery was ligated after removal ofthe catheter. Aortae were harvested 1, 7, and 14 d after the intervention. For RNA extraction, radioimmunoassay of IGF-I and IGF-I binding studies the tissues were stripped of adventitia and immediately frozen in liquid nitrogen. For in situ hybridization studies, tissues were immersed in 4% paraformaldehyde and in 15% sucrose and after embedding in OCT frozen at -70'C.
IGF-I radioimmunoassay. IGF-I was immunoassayed by a heterologous equilibrium technique (8) using rabbit anti-hIGF-I polyclonal antibody (UBK487) distributed through the Hormone Distribution Program of National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, of the National Hormone and Pituitary Program. This antiserum reacts with IGF-I ofseveral species, including that of rat, and cross-reacts < 0.05% with hIGF-II. Oaks, CA) was used for standards, with a minimal detectable dose of 2.0-3.0 pg. Serum was cleared by centrifugation and l-ml aliquots acidified with 1 M acetic acid for 60 min, and filtered through an MPS-l micropartition system (l0,000-D cutoff; Amicon, Beverly, MA) to remove IGF-I binding proteins. Recovery of '25I-IGF-I was 85-93%.
RNase protection assay. Total RNA was extracted from frozen tissues with guanidium thiocyanate using a commercially available kit (Cinna/Biotech Labs, Friendswood, TX). A modification of the method by Melton et al. (9) was used for RNase protection assay. Briefly, 40jg of tissue total RNA were resuspended in a hybridization buffer containing 20 mM Tris HCI, pH 7.6, 1 mM EDTA, 0.4 M NaCl, 0.1% SDS, 75% deionized formamide, and 200,000 cpm of labeled riboprobe. The mixture was heated to 850C for 5 min and then incubated at 450C for 16 h. 40gg/ml RNase A and 2 Mg/ml RNase Tl were then added for 1 h at 30'C. The mixture was then incubated with SDS (final concentration 0.6%) and 150 Mg/ml proteinase K for 15 min at 370C, and then phenol/chloroform extracted. After addition of 20 Mg of tRNA, the RNA was precipitated in 2 vol of ethanol at -20'C. Pellets containing the labeled RNA hybrids were resuspended in a gel loading buffer containing 80% deionized formamide, and size separated on an 8% polyacrylamide/8 M urea denaturing gel. After autoradiography, protected RNA bands were quantified by scanning densitometry.
In situ hybridization. 8-Mm thick sections were mounted on sylilated glass slides and further fixed in 4% paraformaldehyde. After immersion in 0.5x standard saline citrate (SSC) (I X SSC equals 0.15 M sodium chloride, 0.15 M sodium citrate, pH 7.0) and 5 Mg/ml proteinase K solution, slides were prehybridized in a solution containing 50% formamide, 0.3 M NaCl, 20 mM Tris-HCl, 5 mM EDTA, lx Denhardt's solution, 10% dextran sulfate, and 10 mM DTT for 90 min. Hybridization was performed with 2 M1 (300,000 cpm/Ml) of antisense riboprobe (see below) and I Ml of tRNA for 18-20 h at 500C. After the incubation, slides were washed at high stringency (O.1 X SSC at 52°C for 2 h). Slides were then coated with nuclear emulsion and exposed in a light-tight box with desiccant. They were developed after 4 wk (10). For cell identification, slides were counterstained with hematoxylin/ eosin. Hybridization with liver tissue served as a positive control and hybridization on tissues pretreated with ribonuclease or hybridization with sense riboprobes (see below) served as negative controls.
Riboprobes. The probes used to detect the IGF-I and IGF-I receptor transcripts, kindly provided by Drs. C. Roberts, Jr., and D. LeRoith (National Institutes ofHealth), have been described elsewhere ( 1 1, 12) . Briefly, the IGF-I cRNA construct contains a 322-bp complementary to the class A 5' untranslated region of IGF-I mRNA and protects 322, 297, and 241 bases corresponding to class A, B, and C untranslated regions of IGF-I mRNA, respectively. IGF-I receptor mRNA was detected using a rat riboprobe 265 bases long, complementary to 15 bases of 5' untranslated sequence and to a region encoding the signal peptide and the first 53 amino acids of the alpha subunit of the receptor.
For riboprobe generation the DNA template was transcribed with T7 (IGF-I) or SP6 polymerase (IGF-I receptor) and labeled in vitro with [ 32pJ and 35S-UTP for RNase protection assay and in situ hybridization experiments, respectively. Sense 35S-riboprobe used for negative control in the in situ hybridization studies were reciprocally transcribed with SP6 (IGF-I) and T7 polymerase (IGF-I receptor), respectively.
IGF-I binding assay on SMC crude membranes. Crude membranes were prepared from pooled aortae (n = 10) obtained from control rats and from rats 7 d after denudation according to the method ofHavrankova ( 13) . The tissues were washed in cold saline, and homogenized in an ice cold solution containing 1 mM NaHCO3, 10 Mg/ml leupeptin, 1 trypsin inhibitor unit/ml aprotinin, and 2 mM PMSF in a blender (Polytron; Brinkman Instruments Co., Westbury, NY) and the homogenates centrifuged at 600 g. The supernatant was further centrifuged at 20,000 g, and the final pellets resuspended in Ca"+-free KRB. Protein concentration was determined according to the method ofLowry ( 14) .
1251-IGF-I binding was determined as described by Lowe et al. ( 15) . 50
Ml of Ca++-free KRB/0.1% BSA with or without various concentrations of unlabeled IGF-I were added to 50 Ml Ca"+-free KRB with 3% BSA, 3 mg/ml bacitracin, and -0.15 ng/ml '25I-IGF-I ( 15,000 cpm). '251-IGF-I remaining associated with membranes in the presence of 500 ng/ml of unlabeled IGF-I, and were subtracted from total binding to yield the specific binding. To determine whether the differences in binding were due to changes in receptor affinity or number, competition/ inhibition experiments were performed and data plotted according to the method of Scatchard ( 16) . Statistical analysis. The significance of differences was determined using analysis of variance.
Results
Total IGF-I mRNA content in the aortae from rats before, 1, 7, and 14 d after denudation was determined using a solution hybridization/RNase protection assay (Fig. 1) . Consistent with our previous report only class C 5' untranslated mRNA was present in aortic tissue and its content increased severalfold after denudation. Liver is the major source of circulating IGF-I levels (4). The expression of IGF-I mRNA in the liver was not affected by the aortic denudation (data not shown), indicating that activation of aortic IGF-I gene expression occurs in response to local, and not systemic, stimuli. Fig. 2 , a and b, shows examples of in situ hybridization in the normal and denuded aortae. In the control rats, hybridization with antisense IGF-I riboprobe localized IGF-I mRNA to medial SMCs. The distribution was fairly uniform among those cells. IGF-I transcripts were present to a lesser extent in the adventitial but not in the endothelial layer. In situ hybridization after denudation also localized IGF-I transcripts to medial SMCs. The intensity of hybridization was markedly increased throughout medial SMCs at 7 d. IGF-I mRNA transcripts were also present in the mesenchymal cells of the neointima. There was marked hybridization of the antisense IGF-I riboprobe to hepatocytes (Fig. 2 c) , used as positive controls for each hybridization experiment. Sense strand IGF-I riboprobe did not hybridize to liver or aortic tissue sections (data not shown).
L DO D1 D3 D7 D14 The time course of tissue concentration of radioimmunoassayable IGF-I in the aorta after denudation is shown in Fig. 3 . Tissue immunoassayable IGF-I increased from -25 ng/g in control aortic tissue to a maximum of 72 ng/g 7 d after denudation. Serum IGF-I levels did not change at any time after denudation (data not shown).
The biological effects of IGF-I are mediated through interaction with its specific receptor and are dependent in part on ligand and receptor gene expression, and translocation of the receptor to the plasma membrane. Aortic tissue IGF-I receptor mRNA content was determined using a solution hybridization/RNase protection assay (Fig. 4) . Aortic IGF-I receptor mRNA content decreased to 71 ± 10% of control in aortae harvested 7 d after denudation. In liver the expression of IGF-I receptor mRNA was minimal, consistent with previous data that the IGF-I receptor is not present in hepatocytes ( 15) . Fig. 2 , dand e, shows examples ofin situ hybridization with the antisense IGF-I receptor riboprobe in the normal and denuded rat aortae 7 d after denudation. The IGF-I receptor riboprobe hybridized to medial SMC in the normal aortae. At 7 d after denudation, when neointimal proliferation was present, the hybridization was predominantly to the neointimal SMC. At all time points studied there were also adventitial cells containing IGF-I receptor mRNA transcripts. There was no appreciable hybridization ofantisense IGF-I receptor riboprobe with liver ( Fig. 2 f) . Sense strand riboprobe (negative control) failed to hybridize to the aortic tissue sections (data not shown).
We examined whether the decreased expression of IGF-I receptor mRNA at 7 d also resulted in changes in IGF-I binding to crude membrane preparation of aortic tissue. After injury, there was an -40% decrease of specific '251I-IGF-I binding to aortic membranes. To determine whether this decrease in '251-IGF-I binding was due to changes in receptor affinity or number, competition/inhibition experiments were conducted (Fig. 5) . When the data were plotted according to the method of Scatchard, a straight line was obtained, indicating the presence of a single class of binding sites. There was no change in receptor affinity (Kd: 3.88 nM and 3.34 nM, control and 7 d after denudation, respectively). There was, however a marked decrease in receptor number in the injured vessels 7 
Discussion
In this study we show that after balloon denudation, induction of aortic IGF-I gene expression is associated with downregulation of its receptor. This suggests that IGF-I may act in a paracrine fashion in the process of vascular repair after balloon injury. Indeed, there is growing evidence that SMC proliferation at the site ofarterial injury might be modulated in part by a number of locally produced growth factors, such as PDGF-A chain (3) and fibroblast growth factor ( 17) . As IGF-I functions as a progression factor for mitogen-induced vascular SMC growth, we and others have suggested that local IGF-I production may also be involved in the process of healing ofthe injured arterial wall (7, 18) . For locally produced IGF-I to play a role in this process, it is important to show that the IGF-I mRNA tran- scripts are actually translated, to identify the cells that produce it, and to determine that it exerts its effects through its specific receptor.
Consistent with our initial observation (7) (25) . As the media is stretched and often damaged by balloon inflation, it is reasonable to assume that local production ofIGF-I may play a role in regenerating the elastic layer.
The factors that regulate vessel wall IGF-I gene expression have not been determined. Growth hormone is a well established endocrine regulator of IGF-I gene expression, predominantly in liver (4) . In our study denudation did not appreciably change liver IGF-I mRNA content nor plasma IGF-I levels. In addition, our studies in hypophysectomized rats have shown that while basal IGF-I mRNA content in the rat aorta is decreased, the relative increase after denudation is well preserved (26) . These findings suggest that other factors, most likely local, regulate IGF-I gene expression in the vessel wall in response to injury. These factors have yet to be determined. One possible candidate is PDGF, shown to be capable of IGF-I induction in cultured mesenchymal cells (27) . PDGF could potentially arise from adhering platelets or, more likely, from local expression by SMC or regenerating endothelium (28, 29) . The significance ofthe potential synergism between PDGF and IGF-I in vascular repair is highlighted by studies in porcine skin wounds (30) . The 
